ReviewInternational journal of molecular sciences2023

Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication.

Ing S Tiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.